{
    "clinical_study": {
        "@rank": "141468", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells. It is\n      not yet known whether docetaxel plus gemcitabine is more effective than docetaxel plus\n      cisplatin in treating advanced pancreatic cancer.\n\n      PURPOSE: Randomized phase II trial to compare the effectiveness of docetaxel and gemcitabine\n      with that of docetaxel and cisplatin in treating patients who have metastatic or locally\n      advanced pancreatic cancer."
        }, 
        "brief_title": "Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer", 
        "condition": "Pancreatic Cancer", 
        "condition_browse": {
            "mesh_term": "Pancreatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Assess the efficacy of docetaxel and gemcitabine vs docetaxel and cisplatin\n      in patients with metastatic or locoregionally advanced pancreatic cancer. II. Assess the\n      toxicity, response rate, duration of response, time to progression, survival, performance\n      status, and weight associated with these treatment regimens in these patients.\n\n      OUTLINE: This is a randomized, open label, multicenter study. Patents are randomized to one\n      of two treatment arms. Arm I: Patients receive gemcitabine IV over 30 minutes on days 1 and\n      8 and docetaxel IV over 1 hour on day 8. Arm II: Patients receive docetaxel IV over 1 hour\n      followed by cisplatin IV over 1 hour on day 1. Treatment is repeated every 21 days for 6\n      courses in the absence of disease progression or unacceptable toxicity. Patients are\n      followed every 6 weeks until disease progression, and then every 8 weeks until death.\n\n      PROJECTED ACCRUAL: Up to 82 patients (41 per arm) will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically or cytologically confirmed metastatic or\n        locoregionally advanced (with metastatic lymph nodes) unresectable adenocarcinoma of the\n        exocrine pancreas Bidimensionally measurable disease outside previously irradiated fields\n        No CNS involvement or leptomeningeal disease\n\n        PATIENT CHARACTERISTICS: Age: 18 and over Performance status: WHO 0-1 Life expectancy: Not\n        specified Hematopoietic: WBC at least 3,000/mm3 Platelet count at least 100,000/mm3\n        Hepatic: Bilirubin less than 1.5 times the upper limit of normal (ULN) Renal: Creatinine\n        no greater than ULN Other: No prior second malignancy in the past 10 years except\n        carcinoma in situ of the cervix or basal or squamous cell carcinoma of the skin No\n        psychological, familial, sociological, or geographical condition that precludes study\n        compliance Not pregnant or nursing Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: No prior immunotherapy Chemotherapy: No prior\n        chemotherapy Endocrine therapy: Not specified Radiotherapy: Concurrent radiotherapy\n        allowed if indicator lesions not included in irradiated field See Disease Characteristics\n        Surgery: Not specified Other: No concurrent investigational drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 7, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004884", 
            "org_study_id": "EORTC-40984", 
            "secondary_id": "EORTC-40984"
        }, 
        "intervention": [
            {
                "intervention_name": "cisplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "docetaxel", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "gemcitabine hydrochloride", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Gemcitabine", 
                "Docetaxel", 
                "Cisplatin"
            ]
        }, 
        "keyword": [
            "stage III pancreatic cancer", 
            "recurrent pancreatic cancer", 
            "adenocarcinoma of the pancreas", 
            "stage IV pancreatic cancer"
        ], 
        "lastchanged_date": "September 20, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-40984"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Hopital Universitaire Erasme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "Institut Jules Bordet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "National Cancer Institute of Egypt"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boulogne Billancourt", 
                        "country": "France", 
                        "zip": "F-92104"
                    }, 
                    "name": "CHU Ambroise Pare"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre-les-Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Centre Alexis Vautrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amberg", 
                        "country": "Germany", 
                        "zip": "D-92224"
                    }, 
                    "name": "Klinikum St. Marien"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "zip": "D-45122"
                    }, 
                    "name": "Universitaetsklinik und Strahlenklinik - Essen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany", 
                        "zip": "D-60590"
                    }, 
                    "name": "Klinikum der J.W. Goethe Universitaet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hagen", 
                        "country": "Germany", 
                        "zip": "58095"
                    }, 
                    "name": "Marien Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "D-20099"
                    }, 
                    "name": "Hermann-Holthusen Institute for Radiotherapy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "D-30625"
                    }, 
                    "name": "Medizinische Hochschule Hannover"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Neustadt", 
                        "country": "Germany", 
                        "zip": "D-01844"
                    }, 
                    "name": "Praxis Innere Medizin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "D-89081"
                    }, 
                    "name": "Klinikum der Universitaet Ulm"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roermond", 
                        "country": "Netherlands", 
                        "zip": "6043 CV"
                    }, 
                    "name": "Saint Laurentius Ziekenhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland", 
                        "zip": "02-781"
                    }, 
                    "name": "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey", 
                        "zip": "35340"
                    }, 
                    "name": "Dokuz Eylul University School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G11 6NT"
                    }, 
                    "name": "Beatson Oncology Centre"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Egypt", 
                "France", 
                "Germany", 
                "Netherlands", 
                "Poland", 
                "Turkey", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Randomized Phase II Study of Docetaxel/Gemcitabine vs. Docetaxel/Cisplatin in Metastatic or Locoregionally Advanced Pancreatic Carcinoma", 
        "overall_official": {
            "affiliation": "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm", 
            "last_name": "Manfred Lutz, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2001", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004884"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "16361622", 
                "citation": "Lutz MP, Van Cutsem E, Wagener T, Van Laethem JL, Vanhoefer U, Wils JA, Gamelin E, Koehne CH, Arnaud JP, Mitry E, Husseini F, Reichardt P, El-Serafi M, Etienne PL, Lingenfelser T, Praet M, Genicot B, Debois M, Nordlinger B, Ducreux MP; European Organisation for Research and Treatment of Cancer Gastrointestinal Group. Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group. J Clin Oncol. 2005 Dec 20;23(36):9250-6."
            }, 
            {
                "citation": "Lutz MP, Ducreux M, Wagener T, et al.: Docetaxel/gemcitabine or docetaxel/cisplatin in advanced pancreatic carcinoma: a randomized phase II study of the EORTC-GI group. [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-498, 2002."
            }
        ], 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 1999", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }, 
    "geocoordinates": {
        "Beatson Oncology Centre": "55.864 -4.252", 
        "CHU Ambroise Pare": "48.843 2.238", 
        "Centre Alexis Vautrin": "48.661 6.174", 
        "Dokuz Eylul University School of Medicine": "38.419 27.129", 
        "Hermann-Holthusen Institute for Radiotherapy": "53.557 9.995", 
        "Hopital Universitaire Erasme": "50.85 4.352", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Institut Jules Bordet": "50.85 4.352", 
        "Klinikum St. Marien": "49.44 11.863", 
        "Klinikum der J.W. Goethe Universitaet": "50.111 8.682", 
        "Klinikum der Universitaet Ulm": "48.404 9.979", 
        "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology": "52.23 21.012", 
        "Marien Hospital": "51.367 7.463", 
        "Medizinische Hochschule Hannover": "52.384 9.727", 
        "National Cancer Institute of Egypt": "30.044 31.236", 
        "Praxis Innere Medizin": "49.933 9.569", 
        "Saint Laurentius Ziekenhuis": "51.192 5.995", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitaetsklinik und Strahlenklinik - Essen": "51.462 7.009"
    }
}